Marker | Group | Male | Female | Z | P | ||
---|---|---|---|---|---|---|---|
Median | P25, P75 | Median | P25, P75 | ||||
CTX-II (ng/mmol.cre) | EC | 29.19 | 25.17, 40.77 | 30 | 25.57, 35.00 | − 0.102 | 0.918 |
IC | 30.28 | 24.75, 37.02 | 26.65 | 22.80, 32.34 | − 1.663 | 0.096 | |
KBD | 39.71 | 30.34, 62.45 | 45.68 | 29.02, 57.94 | − 0.04 | 0.968 | |
C2C (ng/mmol.cre) | EC | 1.49 | 1.16, 1.73 | 1.51 | 1.27, 1.89 | 1.051 | 0.293 |
IC | 1.67 | 1.27, 2.17 | 1.67 | 1.25, 1.99 | − 0.718 | 0.473 | |
KBD | 1.99 | 1.35, 3.53 | 2.06 | 1.47, 3.08 | 0.283 | 0.777 | |
PYD (nmol/mmol.cre) | EC | 21.23 | 16.76, 28.50 | 23.39 | 18.93, 29.09 | 1.079 | 0.28 |
IC | 24.98 | 21.39, 30.72 | 24.93 | 19.72, 29.23 | − 0.455 | 0.649 | |
KBD | 30.44 | 20.77, 51.37 | 32.07 | 20.62, 46.49 | 0.364 | 0.716 | |
Helix-II (nmol/mmol.cre) | EC | 0.35 | 0.22, 0.45 | 0.33 | 0.28, 0.45 | 0.884 | 0.377 |
IC | 0.37 | 0.27, 0.48 | 0.35 | 0.27, 0.53 | 0.42 | 0.674 | |
KBD | 0.45 | 0.31, 0.70 | 0.46 | 0.32, 0.80 | 0.299 | 0.765 |